Vedolizumab Chemical Properties

storage temp. 

Store at -80°C

solubility 

Soluble in DMSO

form 

Solid

color 

White to off-white

Vedolizumab Usage And Synthesis

Clinical Use

Monoclonal antibody:
Treatment of ulcerative colitis and Crohn’s disease

Drug interactions

Potentially hazardous interactions with other drugs
Live vaccines: risk of generalised infections - avoid.

Metabolism

The expected consequence of metabolism is proteolytic degradation to small peptides and individual amino acids, and receptor-mediated clearance. The exact elimination route of vedolizumab is unknown although renal clearance is expected to be negligible.

Vedolizumab(943609-66-3)Related Product Information

• Follicle stimulating hormone
• Secukinumab
• Daratumumab
• OMALIZUMAB
• Dulaglutide
• Trastuzumab emtansine
• Ranibizumab
• palivizumab
• Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
• Eculizumab
• Matuzumab
• ticilimumab tremelimumab
• CNTO 148
• Aflibercept
• abciximab
• Avelumab
• nimotuzumab
• belimumab